Date: 14 August 2017
NIHR is the latest research funder to sign up to an international joint statement, developed by the World Health Organization (WHO), pledging to ensure clinical trials will be both registered and their results released.
We are backing the initiative, to further reduce avoidable waste in research, improve transparency and strengthen the validity and value of the research base.
The pledge, which is in line with our existing policy on Adding Value in Research, will mean that all our fully funded studies will be required to register in a publicly accessible database and make sure all results are disclosed in a timely way.
We are the largest national clinical research funder in Europe and have played a major role internationally in reducing avoidable waste in research. This endorsement demonstrates our continued leadership and commitment.
We will now be developing a policy and working with our research communities to ensure that our fully funded clinical trials are compliant with the initiative.
Other signatories include UK’s Medical Research Council, Department for International Development, The Wellcome Trust, Médecins Sans Frontières, and the Bill and Melinda Gates Foundation.
Matt Westmore, NIHR lead for this area of work said: “Improving the transparency and openness of science is good for researchers, research funders and good for the quality and integrity of science. Above all it is good for patients and participants in trials. This is an important initiative and NIHR is an important funder – I think it is fantastic we will be working the WHO and other funders to make a difference.”
You may also be interested in